|Articles|March 29, 2021
Secondary Progressive Multiple Sclerosis: Patient Impact and Coverage Implications for New Therapies
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
FAQ: The uncertain future of enhanced ACA premium subsidies and what it means for U.S. healthcare
2
Myqorzo is now available for rare heart condition at a $108,400 annual price
3
Don’t let ‘sleepmaxxing’ keep you up at night: Results from the 2025 American Academy of Sleep Medicine survey on sleep tracking
4
When it comes to quality measures, fewer is viewed as better, says Ben Shirley of PQA | Part 2
5



















